Akita Hidetoshi, Okamura Takehiko, Ando Ryosuke, Nagata Daisuke, Naruyama Hiromichi, Yamada Yasuyuki, Naiki Taku, Yasui Takahiro, Tozawa Keiichi, Kohri Kenjiro
Department of Urology, JA Aichi Anjo Kosei Hospital, Anjo, Japan.
Asian Pac J Cancer Prev. 2011;12(11):2959-61.
There is ongoing discussion as to the necessity for certain surgical procedures being limited to high through-put institutions. To cast light on this question regarding use of open as compared to laparoscopic radical prostatectomy (LRP) the present study was conducted focusing on biochemical (PSA) recurrence-free survival of Japanese patients with clinically localized prostate carcinomas.
From April 2004 to December 2010 we identified 579 patients undergoing LRP (n=245) and retropubic radical prostatectomy (RRP) (n=334) who did not undergo immediate adjuvant therapy (radiation and/or hormonal) and whose PSA levels were lower than 25 ng/ml. Preoperative prostate specific antigen (PSA) level, clinical stage, biopsy Gleason score and pathological features were assessed and Kaplan-Meier estimates of biochemical recurrence (BCR)-free survival were compared. A Cox regression model analysis was performed to determine predictors of biochemical recurrence.
Median follow up was 35 months(2- 115). On univariate analysis the LRP group had a slightly lower pathological T stage (p<0.001), higher biopsy Gleason score (p<0.001), but much more organ confined disease (p=0.001) than the RRP group. BCR-free survival did not significantly differ between LRP and RRP groups with preoperative PSA <6, clinical stage T1c,T2a, pathological stage T3 or more, biopsy Gleason score of 8 or more, pathological Gleason score of 6 or less and 8 or more, extra-capsular extension and negative surgical margin. The 3-year BCR-free survival rates were 91.0%(RRP) and 82.2%(LRP) (p<0.001).
We conclude that in general LRP may be associated with a less positive outcome than BCR for resection of low risk prostate cancers. Therefore indications for LRP should be very carefully monitored.
关于某些外科手术是否有必要局限于高吞吐量机构,目前仍在讨论中。为了阐明与腹腔镜根治性前列腺切除术(LRP)相比开放性手术的使用问题,本研究聚焦于日本临床局限性前列腺癌患者的生化(PSA)无复发生存情况展开。
从2004年4月至2010年12月,我们确定了579例接受LRP(n = 245)和耻骨后根治性前列腺切除术(RRP)(n = 334)的患者,这些患者未接受即刻辅助治疗(放疗和/或激素治疗)且PSA水平低于25 ng/ml。评估术前前列腺特异性抗原(PSA)水平、临床分期、活检Gleason评分和病理特征,并比较生化复发(BCR)无复发生存的Kaplan-Meier估计值。进行Cox回归模型分析以确定生化复发的预测因素。
中位随访时间为35个月(2 - 115个月)。单因素分析显示,与RRP组相比,LRP组的病理T分期略低(p < 0.001),活检Gleason评分更高(p < 0.001),但器官局限性疾病更多(p = 0.001)。术前PSA < 6、临床分期T1c、T2a、病理分期T3或更高、活检Gleason评分为8或更高、病理Gleason评分为6或更低以及8或更高、包膜外侵犯和手术切缘阴性的LRP组和RRP组之间,BCR无复发生存无显著差异。3年BCR无复发生存率分别为91.0%(RRP)和82.2%(LRP)(p < 0.001)。
我们得出结论,一般而言,对于低风险前列腺癌的切除,LRP的预后可能不如BCR。因此,LRP的适应证应受到非常仔细的监测。